1. Screening Libraries
  2. Anti-Cancer Compound Library

Anti-Cancer Compound Library

(1651 compounds) Cat. No.: HY-L025
Library Contents: XLSX PDF

A unique collection of 1651 bioactive anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS).

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

sales@MedChemExpress.com

Top Publications Citing Use of Products

Customer Validation

MCE Screening Library Partners

  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 1651 bioactive anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS).

•   Targets include kinases, cell cycle key components, tumorigenesis related signaling pathways, popular targets in epigenetic studies, and more.

•   A useful tool for the discovery of anti-cancer drugs.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   Detailed compound information with structure, IC50, and brief introduction.

•   Validated NMR and HPLC to ensure high purity and quality.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 1651 anti-cancer compounds supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Contents of Anti-Cancer Compound Library

Plate layout: HY-L025-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty SKF-96365 (hydrochloride) MRT68921 (hydrochloride) CBR-5884 Calcitriol HLCL-61 (hydrochloride) Flavopiridol Flavopiridol (Hydrochloride) SNS-032 Ko 143 KNK437 Empty
b Empty TA-01 AZD-5438 4-IBP SMER28 HC-067047 EAI045 RSL3 (1S,3R-) EPZ015866 Madrasin SZL P1-41 Empty
c Empty Nutlin (3a) CL-82198 MS049 DMCM (hydrochloride) MRK-016 E4CPG Nigericin (sodium salt) BH3I-1 NKL 22 F16 Empty
d Empty PF-04979064 Ro 67-7476 PHCCC FCCP LY2365109 (hydrochloride) CCF642 HA15 WYE-125132 AEE788 TCS-OX2-29 Empty
e Empty HO-3867 A-804598 Bay 59-3074 ITSA-1 Necrosulfonamide Y-27632 GMX1778 Triapine Navitoclax Zibotentan Empty
f Empty LY294002 AS-605240 IC-87114 TG100-115 TGX-221 PI-103 (Hydrochloride) AZD1152-HQPA AZD1152 ZM-447439 Veliparib (dihydrochloride) Empty
g Empty Nilotinib Nilotinib (monohydrochloride monohydrate) Tozasertib Olaparib IMD-0354 MLN8054 Dasatinib Dasatinib (hydrochloride) Linsitinib NVP-TAE 684 Empty
h Empty AZD-1480 YM-155 BMS-754807 Sorafenib Sorafenib (Tosylate) Tandutinib OSI-930 Cediranib Amuvatinib Pazopanib Empty

Plate layout: HY-L025-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Masitinib 17-AAG BIIB021 NVP-AUY922 Everolimus Rapamycin Vorinostat CUDC-101 Panobinostat Belinostat Empty
b Empty Bortezomib Motesanib Motesanib (Diphosphate) Saracatinib BRAF inhibitor GSK-690693 AG1024 PD0325901 Sunitinib Vandetanib Empty
c Empty Afatinib Afatinib (dimaleate) BMS-536924 SB 202190 GSK2126458 GSK-923295 PIK-294 PD173074 BIBX 1382 D4476 Empty
d Empty CL-387785 GW788388 Toceranib Toceranib (phosphate) Regorafenib Regorafenib (monohydrate) Brivanib (alaninate) Brivanib Foretinib KW-2449 Empty
e Empty KX2-391 (dihydrochloride) Fasudil (Hydrochloride) Enzastaurin AZD 6482 AKT inhibitor VIII MK 2206 BI-78D3 Canertinib (dihydrochloride) Pim1/AKK1-IN-1 PP121 Empty
f Empty SU5416 CTS-1027 SCIO-469 SU 5402 TG-101348 TG101209 AZD-8055 OSI-027 PHA-848125 XCT790 Empty
g Empty SB-431542 A 83-01 Vismodegib Pralatrexate Capsaicin MLN9708 Carfilzomib PF-562271 (besylate) PF-573228 PP 242 Empty
h Empty AM580 Dinaciclib BMS-794833 Lexibulin SU14813 SU14813 (maleate) Orteronel BI-D1870 BX795 TSU-68 Empty

Plate layout: HY-L025-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty BMS-345541 BMS-345541 (free base) CGP 57380 GSK1904529A Telatinib Tasquinimod Betulinic acid GW 5074 Tariquidar (methanesulfonate, hydrate) PD 169316 Empty
b Empty Pluripotin BIO Y-27632 (dihydrochloride) Valproic acid (sodium salt) 5-Azacytidine IQ-1 A-966492 Rucaparib (phosphate) MK-4827 MK-4827 (tosylate) Empty
c Empty MK-6892 PKI-402 EG00229 CCT 137690 Pemetrexed (disodium) Delamanid UNC0321 VER-155008 NVP-BEP800 GNF-7 Empty
d Empty RG7112 CYT387 CYT387 (sulfate salt) DMXAA SB-590885 Obatoclax Alisertib Tivozanib Lenvatinib Amonafide Empty
e Empty Pomalidomide ENMD-2076 (Tartrate) ENMD-2076 PCI-24781 MGCD-265 analog AZD-7762 MK-1775 PCI-32765 Trametinib Trametinib (DMSO solvate) Empty
f Empty GSK429286A PHA-793887 CP-466722 GW843682X AZ 628 BX-912 KU-57788 GNF-2 CGP60474 TDZD-8 Empty
g Empty WAY-262611 Icilin Alendronate (sodium hydrate) PI3K inhibitor X BIBF 1120 (esylate) PHA-665752 AG-490 SNS-314 Erlotinib (Hydrochloride) Pazopanib (Hydrochloride) Empty
h Empty BMS-599626 (Hydrochloride) HA14-1 PD153035 (Hydrochloride) SU11274 BSI-201 KU-55933 PF-04217903 PF-04217903 (methanesulfonate) Vatalanib SGX-523 Empty

Plate layout: HY-L025-4

1 2 3 4 5 6 7 8 9 10 11 12
a Empty INO-1001 Andarine Alvespimycin (hydrochloride) Serdemetan WZ4002 PD98059 PIK-90 U0126 2-Methoxyestradiol WYE-354 Empty
b Empty AMG-208 GSK1059615 Rigosertib (sodium) Ki8751 Elesclomol SP600125 AS703026 SB 525334 Cabozantinib (S-malate) HMN-214 Empty
c Empty PIK-93 Ponatinib CCT129202 CP-673451 Vinorelbine (ditartrate) Hesperadin BIX02188 BIX02189 Vemurafenib AT7867 Empty
d Empty AT7867 (dihydrochloride) KRN-633 KU-60019 PD318088 PHT-427 R406 PI3K-IN-1 SB-743921 DPH LDN193189 Empty
e Empty LDN193189 (Hydrochloride) LY2109761 BMS 777607 Oprozomib Poloxin Volasertib Entinostat Mocetinostat TAK-901 PFK-158 Empty
f Empty PFK-015 PF-06463922 MM-102 (trifluoroacetate) IWR-1 CID755673 SB-366791 CB-839 DMH-1 ML347 FR 180204 Empty
g Empty MI 2 (MALT1 inhibitor) AZ191 MLN1117 PI-1840 YH239-EE Defactinib IM-12 WH-4-023 Kenpaullone IOX1 Empty
h Empty AZD8186 KRCA-0008 HTH-01-015 UNC0379 ML216 UNC2025 UNC2025 (hydrochloride) SB-3CT C75 (trans) 6H05 (trifluoroacetate) Empty

Plate layout: HY-L025-5

1 2 3 4 5 6 7 8 9 10 11 12
a Empty PFI-3 G007-LK Y15 A-1210477 BMH-21 LY-2584702 (tosylate salt) LY3023414 OF-1 Oltipraz Ro-3306 Empty
b Empty LY3009120 A-366 Thiamet G ON123300 SP2509 Acalisib Y16 Entrectinib Glutaminase C-IN-1 BPTES Empty
c Empty 10058-F4 ML324 SCR7 AZD3965 ML141 YHO-13177 YHO-13351 (free base) GNE-317 BLZ945 IC261 Empty
d Empty L-779450 Vps34-IN-1 STF-118804 EHop-016 TH588 BLU9931 GSK503 Brigatinib CB-5083 AZD-8835 Empty
e Empty RBC8 CASIN BQU57 PBTZ169 AMG319 ML204 (hydrochloride) R-268712 TP-0903 SGI-7079 AZ6102 Empty
f Empty Spautin-1 Quizartinib Torin 2 Torin 1 PF-3758309 CH5424802 CH5424802 (Hydrochloride) RepSox Cabozantinib GSK1838705A Empty
g Empty CC-401 (hydrochloride) DCC-2036 CAL-101 (+)-JQ-1 (R)-(-)-JQ1 Enantiomer GSK 525762A CDK-IN-2 LY2784544 Cediranib (maleate) Sapitinib Empty
h Empty Daun02 Daunorubicin (Hydrochloride) Cobimetinib Isobavachalcone E-7050 T0070907 NVP-TAE 226 (E)-2-Decenoic acid Avasimibe Crenolanib Empty

Plate layout: HY-L025-6

1 2 3 4 5 6 7 8 9 10 11 12
a Empty LY2157299 SD-208 YM-201636 I-BET151 LY2228820 LY2940680 GDC-0980 MK-5108 AMG 900 TAME Empty
b Empty OSI-420 Thiazovivin NVP-BHG712 MG-132 CCT128930 A66 CHIR-124 WP1130